<?xml version="1.0" encoding="UTF-8"?>
<ref id="B147-molecules-25-04677">
 <label>147.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Setoguchi</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Iimura</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Sugimoto</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Yoneda</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Chiba</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Watanabe</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Muro</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Iigo</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Takayama</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Mika Yokoyama</surname>
    <given-names>A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Identification of trans-4-[1-[[7-fluoro-2-(1-methyl-3-indolyl)-6-benzoxazolyl] acetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid as a potent, orally active VLA-4 antagonist</article-title>
  <source>Bioorg. Med. Chem. Lett.</source>
  <year>2012</year>
  <volume>20</volume>
  <fpage>1201</fpage>
  <lpage>1212</lpage>
  <pub-id pub-id-type="doi">10.1016/j.bmc.2011.12.045</pub-id>
 </element-citation>
</ref>
